|
COLL | Collegium Pharmaceutical, Inc |
|
|
COLL | Collegium Pharmaceutical, Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.73 |
| Leverage | 86.04% |
| Market Cap | $ 947.9m |
| PE | 21.65 |
| Dividend Yield | 0.00% |
| Profit | $ 43.8m |
| Margin | 6.61% |
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.